Le Lézard
Classified in: Science and technology, Business
Subjects: CCA, FVT

Tuya to Report Fourth Quarter 2023 Financial Results on February 27, 2024 Eastern Time


SANTA CLARA, Calif., Feb. 8, 2024 /PRNewswire/ -- Tuya Inc. ("Tuya" or the "Company") (NYSE: TUYA; HKEX: 2391), a global leading IoT cloud development platform, today announced that it will report its fourth quarter 2023 unaudited financial results after the market closes on Tuesday, February 27, 2024. 

Tuya's management will hold a conference call at 07:30 P.M. Eastern Time on Tuesday, February 27, 2024 (08:30 A.M. Beijing Time on Wednesday, February 28, 2024) to discuss the financial results. In advance of the conference call, all participants must use the following link to complete the online registration process. Upon registering, each participant will receive details for this conference including an access code, a PIN number (personal access code), the dial-in number, and an e-mail with detailed instructions to join the conference call.

Registration Link: https://www.netroadshow.com/events/login?show=a98d0a81&confId=60968 

The replay will be accessible through March 05, 2024 by dialing the following numbers:

International:                       +1 929 458 6194

United States:                     +1 866 813 9403

Access Code:                        925036

A live and archived webcast of the conference call will also be available at the Company's investor relations website at https://ir.tuya.com/.

About Tuya Inc.

Tuya Inc. (NYSE: TUYA; HKEX: 2391) is a global leading IoT cloud development platform with a mission to build an IoT developer ecosystem and enable everything to be smart. Tuya has pioneered a purpose-built IoT cloud development platform that delivers a full suite of offerings, including Platform-as-a-Service, or PaaS, and Software-as-a-Service, or SaaS, to businesses and developers. Through its IoT cloud development platform, Tuya has enabled developers to activate a vibrant IoT ecosystem of brands, OEMs, partners and end users to engage and communicate through a broad range of smart devices.

Investor Relations Contact

Tuya Inc.
Investor Relations
E-mail: [email protected] 

The Blueshirt Group
Gary Dvorchak, CFA
Phone: +1 (323) 240-5796
Email: gary@blueshirtgroup.com

SOURCE Tuya Inc.


These press releases may also interest you

at 06:35
Ault Alliance Reports Preliminary Revenue of $36 Million for First Quarter 2024
Ault Alliance, Inc. , a diversified holding company ("Ault Alliance," or the "Company"), today announced preliminary revenue of $36 million for the first quarter of 2024, the highest first quarter topline results in the Company's history. The...

at 06:31
Qudian Files Its Annual Report on Form 20-F
Qudian Inc. ("Qudian" or "the Company" or "We") , a consumer-oriented technology company, today announced that it filed its annual report on Form 20-F for the fiscal year ended December 31, 2023 with the Securities and Exchange Commission on April...

at 06:30
AirBoss Awarded Bandolier Contract Valued at up to US$45 million
AirBoss of America Corp. (the "Company" or "AirBoss") today announced that its wholly-owned subsidiary, AirBoss Defense Group ("ADG"), has been awarded a contract valued at up to US$45 million to provide its Bandolier lightweight, multipurpose...

at 06:30
Daqo New Energy Announces Unaudited First Quarter 2024 Results
Daqo New Energy Corp. ("Daqo New Energy," the "Company" or "we"), a leading manufacturer of high-purity polysilicon for the global solar PV industry, today announced its unaudited financial results for the first quarter of 2024. First Quarter 2024...

at 06:30
Leica Biosystems Receives FDA 510(k) Clearance for Aperio GT 450 DX Digital Pathology System with both SVS and Native DICOM
Leica Biosystems is pleased to announce that its flagship digital pathology system, Aperio GT 450 DX, has received 510(k) clearance from the US Food and Drug Administration. Previously sold into the clinical market under an enforcement discretion due...

at 06:17
Local Infusion Opens Infusion Center in New Haven, Connecticut, the Seventh Location to Open in New England
Local Infusion, a technology-driven provider for patients with chronic autoimmune diseases on specialty infusion therapy, announced the opening of a state-of-the-art infusion center in New Haven, Connecticut. We are excited about our continued...

More news about Business...


News published on and distributed by: